Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 25 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/1/1988


1.		Phase II Master Protocol for New Agents in the Treatment of Advanced Colorectal Cancer --- Didemnin B (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-86I3 NCI-T86-0292D, T86-0292


2.		Phase II Study of Chemotherapy with Didemnin B in Patients with Advanced, Measurable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				MDA-DM-87021 NCI-T87-0071C, T87-0071

Last Modified: 8/1/1989


3.		Phase I/II Study of Chemotherapy with Didemnin B in Patients with non-Small Cell Lung Cancer (Summary Last Modified 08/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 and over				NCI				MDA-DM-87027 NCI-T87-0074C, T87-0074

Last Modified: 3/1/1990


4.		Phase II Randomized Evaluation of Chemotherapy with Didemnin B or Trimetrexate in Patients with Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix (Summary Last Modified 03/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				SWOG-8640 SWOG-8640

Last Modified: 11/1/1992


5.		Phase II Chemotherapy with Didemnin B in Patients with Small Cell Lung Cancer (Summary Last Modified 11/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 and over				NCI				MDA-DM-87028 NCI-T87-0073C, T87-0073

Last Modified: 12/1/1990


6.		Phase II Chemotherapy with Didemnin B for Patients with Metastatic Breast Cancer (Summary Last Modified 12/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MDA-DM-87039 NCI-T87-0108C, T87-0108

Last Modified: 4/26/2007


7.		Phase II Chemotherapy with Didemnin B in Patients with Metastatic Adenocarcinoma of the Kidney (Summary Last Modified 03/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8728 SWOG-8728

Last Modified: 9/1/1988


8.		Phase II Chemotherapy with Didemnin B in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 09/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				MSKCC-8787A NCI-T87-0193C, T87-0193

Last Modified: 10/15/2007


9.		Phase II Study of Didemnin B vs IFF/Mesna for Patients with Adenocarcinoma of the Prostate Resistant to Endocrine Treatment and of IFF/Mesna in Patients without Prior Endocrine Manipulation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-8719 SWOG-8719

Last Modified: 10/1/1989


10.		Phase II Chemotherapy with Didemnin B in Patients with Advanced Transitional Cell Carcinoma of the Bladder, Ureter, and Renal Pelvis (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-87U3 NCI-T87-0206D, T87-0206

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute